Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Summer;24(2):67-8.
doi: 10.1155/2013/363250.

Pulmonary mucormycosis in a patient with Crohn disease on immunosuppressive medications including infliximab

Alissa J Wright  1 , Theodore Steiner  1 , Ana Maria Bilawich  2 , John C English  3 , C Frank Ryan  4
Affiliations
Case Reports

Pulmonary mucormycosis in a patient with Crohn disease on immunosuppressive medications including infliximab

Alissa J Wright et al. Can J Infect Dis Med Microbiol. 2013 Summer.
No abstract available

PubMed Disclaimer

Figures

Figure 1)
Figure 1)
Left panelComputed tomography image of the chest (lung window) showing extensive consolidation of the left lung with cavitation extending to the pleural surface.Right panelPhotomicrograph of one region of the cavity showing the surrounding rim of necrotic lung tissue. A prominent pulmonary artery (A) is partially necrotic and infiltrated by fungal hyphae (asterisk: cavity lumen; B: bronchiole). Inset: High-power photomicrograph of the hyphae of the Mucor/Rhizopus species. The hyphae are pauciseptate, of variable thickness and demonstrate a ‘folded tissue’ or ‘ribbon-like’ appearance. Some of the branches can be seen originating at right angles from the parent structure
See this image and copyright information in PMC

References

    1. Kontoyiannis DP, Lewis RE. Agents of mucormycosis and entomophthoramycosis. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 7th edn. Philadelphia: Churchill Livingstone Elsevier; 2010. p. 4028.p. xcvii.
    1. Sun HY, Singh N. Mucormycosis: Its contemporary face and management strategies. Lancet Infect Dis. 2011;11:301–11. - PubMed
    1. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000;13:236–301. - PMC - PubMed
    1. van Dullemen HM, van Deventer SJ, Hommes DW, et al. Treatment of Crohn’s disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2) Gastroenterology. 1995;109:129–35. - PubMed
    1. Gomez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD, BIOBADASER Group Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active-surveillance report. Arthritis Rheum. 2003;48:2122–7. - PubMed

Publication types

LinkOut - more resources